filmov
tv
New clinical trial for OCD patients being tested in South Florida

Показать описание
Obsessive-Compulsive Disorder, or OCD, is one of the top 20 causes of illness-related disability worldwide for people between 15 and 44 years old, according to the World Health Organization.
New clinical trial for OCD patients being tested in South Florida
What You Need to Know About OCD and The New Clinical Trial Underway
New Obsessive-Compulsive Disorder Clinical Trial: BX Pulsar 1002 for Obsessive-Compulsive Disorder
What if | OCD Clinical Trial | Biohaven V8
A New Clinical Trial for OCD | Om Research
New clues on potential cause of OCD
MAC Clinical Research | OCD Clinical Trial
Experimental drug offers hope to those living with OCD
New Treatment For OCD
Clinical Trial: Troriluzole for Obsessive-Compulsive Disorder (NCT04693351)
OCD Clinical Trial - Greater Good
New Obsessive-Compulsive Disorder Clinical Trial: cTBS for Obsessive-Compulsive Disorder
OCD Trial Results
New OCD Treatment Being Tried In Houston
Do you have OCD? A Clinical Trial May Be An Option
What's New in OCD? - Featuring Dr. Eric Hollander (2021)
What If | OCD Clinical Trial | Biohaven V6
'What if...' - A Clinical Trial for OCD
New treatment for OCD under investigation
OCD Clinical Trial | Om Research
Clinical Trial: Psilocybin (0.25mg/kg) for Obsessive-Compulsive Disorder (NCT03356483)
New hope for someone with obsessive compulsive disorder
Clinical Trial: BX Pulsar 1002 for Obsessive-Compulsive Disorder (NCT05467085)
OCD Research Study - Biohaven Pharmaceuticals
Комментарии